Summary
Anti M-protein antibody response has been looked for in sera from individuals with serological evidence of A or B influenza infection using pure M-protein (M) in complement fixation tests (CF), in IgG and in IgA specific enzyme linked immunosorbent assays (ELISA).
Mp ELISA (IgG specific) antibodies are not restricted to people with history of recent respiratory infection. Individuals under 15 years are less prone than those older to display M ELISA activity. Most M ELISA positive individuals are also nucleoprotein (NP) positive. There are more M than NP ELISA positives in the influenza A series whereas the reverse is observed in the influenza B series. Most of the M ELISA positives are also S CF (standard soluble antigen CF) positive indicating that M ELISA IgGs are related to recent infections. Some sera exhibit M ELISA activity with no other evidence of influenza experience than V CF (viral antigen CF) or HI (haemagglutination inhibition), suggesting that some recent influenza infections are better traced with M ELISA than with S CF.
Amongst chronic bronchitis patients with V CF or HI antibodies to A 2 influenza virus but no type A S CF activity, the proportion of M ELISA positives averages 40 per cent. This fact as well as two other features of that group i.e. cases with long lasting S CF activity and occasional virus isolation several months after the initial acute infection, suggest that influenza virus might cause prolonged infection in some patients with chronic bronchitis.
Similar content being viewed by others
References
Cretescu, L., Beare, A. S., Schild, G. C.: Formation of antibody to matrix protein in experimental human influenza A virus infection. Infect. Immun.22, 322–327 (1978).
Joassin, L., Reginster, M.: A convenient method for isolation of the M-protein of influenza virus. FEMS Microbiology letters4, 315–318 (1978).
Mostow, S. R., Schild, G. C., Dowdle, W. R., Wood, R. J.: Application of the single radial diffusion test for assay of antibody to influenza type A viruses. J. Clin. Microbiol.2, 531–540 (1975).
Reginster, M.: Infection pulmonaire chronique et survie du virus grippal entre les épidémies. XIVe Symposium Européen de la Poliomyélite et Autres Maladies à Virus, Ankara, 1973.
Reginster, M.: Aspects épidémiologiques du rôle des virus dans les infections respiratoires aigües. In: Comptes rendus du Symposium “Développements récents en Pathologie respiratoire infectieuse”, 84–97. Amsterdam-Oxford-Princeton: Excerpta Medica 1979.
Reginster, M., Joassin, L., Fontaine-Delcambe, P.: Ligands for antibody to M-protein are exposed at the surface of influenza virions: effect of proteolytic treatment on their activity. J. gen. Virol.45, 283–289 (1979).
Reginster, M., Nermut, M. V.: Preparation and characterization of influenza virus cores. J. gen. Virol.31, 211–220 (1976).
Reginster, M., Rentier, B., Dierickx, L.: Impairment of the M-protein and unmasking of a superficial type-specific antigen by proteolytic treatment of influenza A virions with preservation of host-specific antigenicity. Intervirol.6, 239–248 (1975).
Voller, A., Bidwel, D., Bartlett, A.: Microplate enzyme immunoassays for immunodiagnosis of virus infections. In:Rose, N., Friedman, H. (eds.), Manual of clinical immunology, 506–512. Washington, D.C.: American Society for Microbiology 1976.
Webster, R. G., Hinshaw, V. S.: Matrix protein from influenza A virus and its role in cross protection in mice. Infect. Immun.17, 561–566 (1977).
Author information
Authors and Affiliations
Additional information
With 1 Figure
Rights and permissions
About this article
Cite this article
Joassin, L., Reginster, M. & Vaira, D. Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation. Archives of Virology 76, 15–23 (1983). https://doi.org/10.1007/BF01315700
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01315700